Healthcare >> CEO Interviews >> October 26, 2004
DR. PARKASH GILL, MD and the Founder of VasGene Therapeutics, Inc., is
Professor of Medicine and Pathology at the USC- Norris Comprehensive
Cancer Center. He has over 20 years of experience in clinical and
translational research in oncology. He has over 170 publications. He was
instrumental in the development and FDA approval of Taxol, Daunoxome and
Paxene. He obtained his postgraduate training at the University of
Southern California School of Medicine, where he continues to conduct
basic and translational research in vascular and cancer biology. Profile
Dr. Gill: VasGene Therapeutics was founded in 1998 with the mission of
developing novel therapeutics to target tumor cell and tumor
